429 related articles for article (PubMed ID: 33289919)
1. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.
Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
Cochrane Database Syst Rev; 2020 Dec; 12(12):MR000040. PubMed ID: 33289919
[TBL] [Abstract][Full Text] [Related]
2. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.
Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
BMJ; 2020 Dec; 371():m4234. PubMed ID: 33298430
[TBL] [Abstract][Full Text] [Related]
3. Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality.
Hansen C; Lundh A; Rasmussen K; Hróbjartsson A
Cochrane Database Syst Rev; 2019 Aug; 8(8):MR000047. PubMed ID: 31425611
[TBL] [Abstract][Full Text] [Related]
4. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis.
Fabbri A; Nejstgaard CH; Grundy Q; Bero L; Dunn AG; Mohammad A; Mintzes B
J Gen Intern Med; 2022 Feb; 37(2):290-297. PubMed ID: 34037923
[TBL] [Abstract][Full Text] [Related]
5. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
Lurie P; Almeida CM; Stine N; Stine AR; Wolfe SM
JAMA; 2006 Apr; 295(16):1921-8. PubMed ID: 16639051
[TBL] [Abstract][Full Text] [Related]
6. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review.
Wang AT; McCoy CP; Murad MH; Montori VM
BMJ; 2010 Mar; 340():c1344. PubMed ID: 20299696
[TBL] [Abstract][Full Text] [Related]
7. Industry sponsorship and research outcome.
Lundh A; Lexchin J; Mintzes B; Schroll JB; Bero L
Cochrane Database Syst Rev; 2017 Feb; 2(2):MR000033. PubMed ID: 28207928
[TBL] [Abstract][Full Text] [Related]
8. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews.
Mandrioli D; Kearns CE; Bero LA
PLoS One; 2016; 11(9):e0162198. PubMed ID: 27606602
[TBL] [Abstract][Full Text] [Related]
10. Industry sponsorship and research outcome.
Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L
Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Revisiting financial conflicts of interest in FDA advisory committees.
Pham-Kanter G
Milbank Q; 2014 Sep; 92(3):446-70. PubMed ID: 25199895
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines.
Murayama A; Kamamoto S; Murata N; Yamasaki R; Yamada K; Yamashita E; Saito H; Tanimoto T; Ozaki A
J Gastroenterol Hepatol; 2023 Apr; 38(4):565-573. PubMed ID: 36518089
[TBL] [Abstract][Full Text] [Related]
14. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
15. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
Elder K; Turner KA; Cosgrove L; Lexchin J; Shnier A; Moore A; Straus S; Thombs BD
CMAJ; 2020 Jun; 192(23):E617-E625. PubMed ID: 32538799
[TBL] [Abstract][Full Text] [Related]
16. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
[TBL] [Abstract][Full Text] [Related]
17. Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.
Fugh-Berman A; McDonald CP; Bell AM; Bethards EC; Scialli AR
PLoS Med; 2011 Mar; 8(3):e1000425. PubMed ID: 21423581
[TBL] [Abstract][Full Text] [Related]
18. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests.
Boyd EA; Bero LA
Health Res Policy Syst; 2006 Dec; 4():16. PubMed ID: 17140441
[TBL] [Abstract][Full Text] [Related]
19. Conflicts of interest and the quality of recommendations in clinical guidelines.
Cosgrove L; Bursztajn HJ; Erlich DR; Wheeler EE; Shaughnessy AF
J Eval Clin Pract; 2013 Aug; 19(4):674-81. PubMed ID: 23731207
[TBL] [Abstract][Full Text] [Related]
20. Multiple session early psychological interventions for the prevention of post-traumatic stress disorder.
Roberts NP; Kitchiner NJ; Kenardy J; Robertson L; Lewis C; Bisson JI
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD006869. PubMed ID: 31425615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
